IP Library Assignment 059228/0141
Patent Assignment
Reel/Frame 059228/0141

Change of Name

Recorded: 2022-03-10 Pages: 3
Assignor
SHUTTLE PHARMACEUTICALS, LLC
Executed: 2016-08-03
Assignee
SHUTTLE PHARMACEUTICALS, INC.
1 RESEARCH COURT, SUITE 450, ROCKVILLE, MARYLAND, 20850
Covered Properties (4)
Dual Function Molecules for Histone Deacetylase Inhibition and Ataxia Telangiectasia Mutated Activation and Methods of Use Thereof
Application: 15/555,386 →
Publication: US 2018/0044292
Dual Function Molecules for Histone Deacetylase Inhibition and Ataxia Telangiectasia Mutated Activation and Methods of Use Thereof
Application: 15/804,746 →
Publication: US 2018/0057456
Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
Application: 16/476,006 →
Publication: US 2020/0071288
Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
Application: 16/959,570 →
Publication: US 2021/0078963
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 4, 2020
From: GRINDROD, SCOTT; JUNG, MIRA; DRITSCHILO, ANATOLY; BROWN, MILTON
To: SHUTTLE PHARMACEUTICALS, LLC
Reel/Frame 052008/0758 →
Assignment of Assignor's Interest Mar 4, 2020
From: GRINDROD, SCOTT; JUNG, MIRA; BROWN, MILTON; DRITSCHILO, ANATOLY
To: SHUTTLE PHARMACEUTICALS, LLC
Reel/Frame 052008/0873 →
Assignment of Assignor's Interest Sep 24, 2020
From: GRINDROD, SCOTT; JUNG, MIRA; DRITSCHILO, ANATOLY
To: SHUTTLE PHARMACEUTICALS, LLC
Reel/Frame 053868/0759 →